DAVID V GOEDDEL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID V GOEDDEL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID V GOEDDEL. DAVID V GOEDDEL is an Chief Executive Officer in TULARIK INC ($TLRK) and a 10% Owner in NGM BIOPHARMACEUTICALS INC ($NGM) and a Director in NGM BIOPHARMACEUTICALS INC ($NGM) and a Director in RAPT Therapeutics, Inc. ($RAPT).
Address: C/O TULARIK INC. 1120 VETERANS BLVD. SO. SAN FRANCISCO 94080 CA
Companies in which DAVID V GOEDDEL is an Insider
NGM BIOPHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID V GOEDDEL: 10% Owner, Director
Holdings: 17,896,978 shares
Latest Transaction: May 22 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
RAPT Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID V GOEDDEL: Director
Holdings: 2,463,659 shares
Latest Transaction: Nov 04 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
TULARIK INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID V GOEDDEL: Chief Executive Officer
Holdings: 0 shares
Latest Transaction: Aug 17 2004
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of DAVID V GOEDDEL
Sentiment: All, NGM, RAPT, TLRK
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 22 2020 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Option Exercise | A | 20.37 | 16,806 | 342,338 | 16,806 | |
| Apr 09 2020 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 14.95 | 112,602 | 1,683,400 | 17,896,978 | 17.8 M to 17.9 M (+0.63 %) |
| Apr 07 2020 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 14.38 | 123,728 | 1,779,209 | 17,784,376 | 17.7 M to 17.8 M (+0.70 %) |
| Apr 07 2020 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 12.41 | 14,587 | 181,025 | 17,660,648 | 17.6 M to 17.7 M (+0.08 %) |
| Apr 02 2020 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 12.40 | 14,850 | 184,140 | 17,646,061 | 17.6 M to 17.6 M (+0.08 %) |
| Apr 02 2020 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 12.26 | 118,067 | 1,447,501 | 17,631,211 | 17.5 M to 17.6 M (+0.67 %) |
| Apr 02 2020 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 12.53 | 118,067 | 1,479,380 | 17,513,144 | 17.4 M to 17.5 M (+0.68 %) |